Metabolic Energy Deficiency Underlies Hypertrophic Cardiomyopathy

MedWire News: Treatment of hypertrophic cardiomyopathy (HCM) with perhexiline ameliorates cardiac energetic impairment, corrects diastolic dysfunction, and increases exercise capacity relative to placebo, a randomized controlled trial shows.